InvestorsHub Logo
icon url

lasers

03/27/13 3:53 PM

#3753 RE: rayrohn #3752

Colangelo is one smart lawyer CEO.

CLI 40 patients treated in Phase3 will be evaluated in the months ahead just as before.

DCM will now be the front runner in Phase2B with 108 patients. Phase 2A had excellent results.

FDA will move more quickly to save deaths such as heart attacks.

JV partners more likely now on DCM.

CLI staff will be reduced and DCM staff boosted.

Expenses cut in half says Colangelo knows the most effective way to boost shareholder PPS value.

icon url

scubastevemd

03/27/13 4:13 PM

#3754 RE: rayrohn #3752

Wish you the best but doubt seriously that this company has much of a future unless someone wants their patents and will buy them out. I really feel the did the groundwork for a new generation of medicine that will soon take it's place.